Edition:
United States

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.49USD
11 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.49
Open
$0.48
Day's High
$0.50
Day's Low
$0.48
Volume
6,918
Avg. Vol
18,138
52-wk High
$1.81
52-wk Low
$0.36

Chart for

About

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being... (more)
No analyst recommendations are available for .

Overall

Beta: 1.82
Market Cap(Mil.): $11.29
Shares Outstanding(Mil.): 22.56
Dividend: --
Yield (%): --

Financials

  DMPI.OQ Industry Sector
P/E (TTM): -- 8.90 18.87
EPS (TTM): -0.47 -- --
ROI: -126.11 7.21 0.39
ROE: -568.91 8.97 16.43

Earnings vs. Estimates